Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Aug-24 4:13 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 12-Aug-24 | Option Exercise | 5,201 | $13.85 | $72,033.90 | 9% 55.19K to 60.4K | |
| 19-Mar-24 4:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-Mar-24 | Private Sale | 9,913 | $56.90 | $564,050.00 | (15%) 64.61K to 54.69K | |
| 13-Feb-24 4:38 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Feb-24 | Private Sale | 597 | $67.77 | $40,456.80 | (< 1%) 65.2K to 64.61K | |
| 31-Jan-24 4:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 29-Jan-24 | Private Sale | 367 | $64.14 | $23,538.70 | (< 1%) 65.57K to 65.2K | |
| 23-Jan-24 6:01 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Jan-24 | Private Sale | 1,384 | $65.00 | $89,954.50 | (2%) 66.95K to 65.57K | |
| 17-Jan-24 4:41 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Grant | 16,963 | -- | -- | 33% 51.62K to 68.58K | |
| 17-Jan-24 4:41 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Sale | 1,631 | $66.81 | $108,965.00 | (2%) 68.58K to 66.95K | |
| 24-Oct-23 4:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 23-Oct-23 | Market Sale | 131 | $46.04 | $6,030.74 | (< 1%) 51.75K to 51.62K | 3% |
| 22-Feb-23 6:46 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Grant | 5,280 | -- | -- | 11% 46.5K to 51.78K | |
| 22-Feb-23 6:46 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Payment of Exercise | 441 | $58.50 | $25,798.50 | (< 1%) 51.78K to 51.34K | |
| 14-Feb-23 4:24 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-23 | Payment of Exercise | 670 | $51.21 | $34,310.70 | (1%) 47.17K to 46.5K | |
| 30-Jan-23 4:45 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jan-23 | Payment of Exercise | 367 | $52.77 | $19,366.60 | (< 1%) 47.54K to 47.17K | |
| 24-Jan-23 5:12 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jan-23 | Payment of Exercise | 1,149 | $52.05 | $59,805.40 | (2%) 48.69K to 47.54K | |
| 17-Jan-23 7:28 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Jan-23 | Grant | 19,634 | -- | -- | 68% 29.05K to 48.69K | |
| 24-Oct-22 5:10 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Oct-22 | Payment of Exercise | 196 | $58.00 | $11,368.00 | (< 1%) 29.25K to 29.05K | |
| 18-Aug-22 4:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Aug-22 | Option Exercise | 5,000 | $15.52 | $77,600.00 | 17% 29.25K to 34.25K | |
| 18-Aug-22 4:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Aug-22 | Planned Option Sale | 5,000 | $69.50 | $347,500.00 | (15%) 34.25K to 29.25K | |
| 12-Aug-22 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 11-Aug-22 | Option Exercise | 5,000 | $15.52 | $77,600.00 | 17% 29.25K to 34.25K | |
| 12-Aug-22 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 11-Aug-22 | Planned Option Sale | 5,000 | $67.00 | $335,000.00 | (15%) 34.25K to 29.25K | |
| 09-Aug-22 5:16 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Aug-22 | Option Exercise | 5,000 | $15.52 | $77,600.00 | 17% 29.25K to 34.25K | |
| 09-Aug-22 5:16 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Aug-22 | Planned Option Sale | 5,000 | $64.50 | $322,500.00 | (15%) 34.25K to 29.25K | |
| 08-Aug-22 4:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 04-Aug-22 | Option Exercise | 10,000 | $15.52 | $155,200.00 | 34% 29.25K to 39.25K | |
| 08-Aug-22 4:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 04-Aug-22 | Planned Option Sale | 10,000 | $60.75 | $607,500.00 | (25%) 39.25K to 29.25K | |
| 28-Jul-22 4:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jul-22 | Option Exercise | 5,000 | $15.52 | $77,600.00 | 17% 29.25K to 34.25K | |
| 28-Jul-22 4:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jul-22 | Planned Option Sale | 5,000 | $57.00 | $285,000.00 | (15%) 34.25K to 29.25K | |
| 21-Jul-22 4:31 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Jul-22 | Option Exercise | 5,000 | $15.52 | $77,600.00 | 17% 29.25K to 34.25K | |
| 21-Jul-22 4:31 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Jul-22 | Planned Option Sale | 5,000 | $56.42 | $282,100.00 | (15%) 34.25K to 29.25K | |
| 21-Jun-22 4:11 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jun-22 | Option Exercise | 10,000 | $13.85 | $138,500.00 | 34% 29.25K to 39.25K | |
| 21-Jun-22 4:11 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jun-22 | Option Sale | 10,000 | $41.78 | $417,850.00 | (25%) 39.25K to 29.25K | |
| 22-Apr-22 5:35 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Apr-22 | Option Exercise | 7,000 | $15.52 | $108,640.00 | 25% 28.48K to 35.48K | |
| 22-Apr-22 5:35 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Apr-22 | Planned Option Sale | 7,000 | $52.53 | $367,710.00 | (20%) 35.48K to 28.48K | |
| 14-Feb-22 10:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-22 | Grant | 4,901 | -- | -- | 21% 23.85K to 28.75K | |
| 14-Feb-22 10:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-22 | Payment of Exercise | 271 | $47.12 | $12,769.50 | (< 1%) 28.75K to 28.48K | |
| 01-Feb-22 6:10 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-22 | Payment of Exercise | 434 | $38.59 | $16,748.10 | (2%) 20.96K to 20.53K | (15%) |
| 25-Jan-22 4:37 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jan-22 | Grant | 10,592 | -- | -- | 102% 10.37K to 20.96K | |
| 27-Oct-21 4:26 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Oct-21 | Grant | 882 | -- | -- | 9% 9.49K to 10.37K | |
| 22-Jul-21 4:24 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jul-21 | Option Exercise | 1,000 | $15.52 | $15,520.00 | 11% 9.49K to 10.49K | |
| 22-Jul-21 4:24 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jul-21 | Market Option Sale (Planned) | 1,000 | $65.00 | $65,000.00 | (10%) 10.49K to 9.49K | |
| 16-Jul-21 6:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Jul-21 | Option Exercise | 1,000 | $15.52 | $15,520.00 | 11% 9.49K to 10.49K | |
| 16-Jul-21 6:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Jul-21 | Market Option Sale (Planned) | 1,000 | $62.30 | $62,300.00 | (10%) 10.49K to 9.49K | |
| 16-Jun-21 4:32 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Jun-21 | Option Exercise | 4,000 | $15.52 | $62,080.00 | 42% 9.49K to 13.49K | |
| 16-Jun-21 4:32 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Jun-21 | Market Option Sale | 4,000 | $64.96 | $259,830.00 | (30%) 13.49K to 9.49K | |
| 19-May-21 4:04 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-May-21 | Option Exercise | 2,000 | $15.52 | $31,040.00 | 21% 9.49K to 11.49K | |
| 19-May-21 4:04 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-May-21 | Market Option Sale (Planned) | 2,000 | $55.00 | $110,000.00 | (17%) 11.49K to 9.49K | (3%) |